Komori
K Pharma (4896) · RiskRestated

Legal and Regulatory Changes and Political Instability Associated with Overseas Expansion

First written in FY2023. 2 of 3 entries say "Restated". Latest entry: FY2025.

3entries
3years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2023 – FY20252024: 120242025: 120252026: 12026
Same theme, other companies
Risks Relating to Laws and Regulations and Political and Economic Conditions in Overseas MarketsA theme 440 companies write about · 446 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2025: 47 of 94 companies on the "Worse" side.

78 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 197 companies compared. The sentences above are computed from all 197.Comparing 200 of the theme's 446 threads.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for K Pharma yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.